These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 22231830)
41. Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies. Dean B Int J Neuropsychopharmacol; 2011 Aug; 14(7):997-1012. PubMed ID: 21156092 [TBL] [Abstract][Full Text] [Related]
42. The neuro-immune axis: prospect for novel treatments for mental disorders. Kraneveld AD; de Theije CG; van Heesch F; Borre Y; de Kivit S; Olivier B; Korte M; Garssen J Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):128-36. PubMed ID: 24118847 [TBL] [Abstract][Full Text] [Related]
46. Revisiting the role of IL-2 in autoimmunity. Dooms H; Abbas AK Eur J Immunol; 2010 Jun; 40(6):1538-40. PubMed ID: 20458706 [TBL] [Abstract][Full Text] [Related]
47. [Role of the cytokine network in the CNS and psychiatric disorders]. Müller N Nervenarzt; 1997 Jan; 68(1):11-20. PubMed ID: 9132617 [TBL] [Abstract][Full Text] [Related]
48. Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus: analysis of some of these actions. Lynch MA Vitam Horm; 2002; 64():185-219. PubMed ID: 11898392 [TBL] [Abstract][Full Text] [Related]
49. Editorial: Update on Translational Neuroimmunology - Research of ISNI 2018. Probert L; Quintana FJ; Bar-Or A Front Immunol; 2020; 11():2012. PubMed ID: 33101268 [No Abstract] [Full Text] [Related]
50. Schizophrenia and psychoneuroimmunology: an integrative view. Sperner-Unterweger B; Fuchs D Curr Opin Psychiatry; 2015 May; 28(3):201-6. PubMed ID: 25768084 [TBL] [Abstract][Full Text] [Related]
51. An updated overview of animal models in neuropsychiatry. Razafsha M; Behforuzi H; Harati H; Wafai RA; Khaku A; Mondello S; Gold MS; Kobeissy FH Neuroscience; 2013 Jun; 240():204-18. PubMed ID: 23473749 [TBL] [Abstract][Full Text] [Related]
52. A quantitative approach to neuropsychiatry: The why and the how. Kas MJ; Penninx B; Sommer B; Serretti A; Arango C; Marston H Neurosci Biobehav Rev; 2019 Feb; 97():3-9. PubMed ID: 29246661 [TBL] [Abstract][Full Text] [Related]
53. Learning and memory ... and the immune system. Marin I; Kipnis J Learn Mem; 2013 Sep; 20(10):601-6. PubMed ID: 24051097 [TBL] [Abstract][Full Text] [Related]
54. Insulin-like growth factor type 1 and its relation with neuropsychiatric disorders. Zegarra-Valdivia JA Medwave; 2017 Aug; 17(7):e7031. PubMed ID: 28863129 [TBL] [Abstract][Full Text] [Related]
55. How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications. Anderson G; Maes M CNS Neurol Disord Drug Targets; 2017; 16(3):266-278. PubMed ID: 27875954 [TBL] [Abstract][Full Text] [Related]
56. Loss of Neuronal Phenotype and Neurodegeneration: Effects of T Lymphocytes and Brain Interleukin-2. Meola D; Huang Z; Ha GK; Petitto JM J Alzheimers Dis Parkinsonism; 2013 Jun; Suppl 10():. PubMed ID: 24058743 [TBL] [Abstract][Full Text] [Related]
57. Vasculitis, Autoimmunity, and Cytokines: How the Immune System Can Harm the Brain. Tesser A; Pin A; Mencaroni E; Gulino V; Tommasini A Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34073717 [TBL] [Abstract][Full Text] [Related]
58. Interleukin-2 and its effects in the central nervous system. Jiang CL; Lu CL Biol Signals Recept; 1998; 7(3):148-56. PubMed ID: 9672758 [TBL] [Abstract][Full Text] [Related]
59. Next-Generation Neuroimmunology: New Technologies to Understand Central Nervous System Autoimmunity. Meyer Zu Hörste G; Gross CC; Klotz L; Schwab N; Wiendl H Trends Immunol; 2020 Apr; 41(4):341-354. PubMed ID: 32147112 [TBL] [Abstract][Full Text] [Related]
60. Cortical release signs in psychiatry. Walterfang M; Velakoulis D Aust N Z J Psychiatry; 2005 May; 39(5):317-27. PubMed ID: 15860018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]